Twist Bioscience Corp expected to post a loss of $1.14 a share - Earnings Preview
02/08/2023 14:54
* Twist Bioscience Corp TWST.OQ TWST.O is expected
to show a
rise in quarterly revenue when it reports results on August 4.
* The South San Francisco California-based company is
expected to
report a 7.9% increase in revenue to $60.544 million from
$56.11 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on May
5 2023, for the period ended June 30, was for revenue between
$60.00 million and $61.00 million.
* Refinitiv's mean analyst estimate for Twist Bioscience
Corp is
for a loss of $1.14 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Twist
Bioscience
Corp is $22, below its last closing price of $22.89.
The company's guidance on May 5 2023 for the period ended June
30 was for gross profit margin of USD30%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -1.10 -1.12 -1.04 Beat 7.2
Dec. 31 2023 -1.12 -1.13 -0.74 Beat 34.7
Sep. 30 2022 -1.25 -1.25 -0.91 Beat 27.1
Jun. 30 2022 -1.31 -1.31 -1.08 Beat 17.5
Mar. -1.28 -1.28 -1.13 Beat 11.5
31 2022
Dec. 31 2021 -1.07 -1.06 -0.91 Beat 14.5
Sep. 30 2021 -0.80 -0.79 -0.84 Missed -5.8
Jun. 30 2021 -0.75 -0.75 -0.78 Missed -3.8
This summary was machine generated August 2 at 13:54 GMT. All
figures in US dollars unless otherwise stated